INFLUENCE OF GASTRIC-ACID ON CIRCULATING SOMATOSTATIN-14 AND SOMATOSTATIN-28 RELEASED AFTER INSULIN-INDUCED HYPOGLYCEMIA IN CONSCIOUS DOGS

被引:7
|
作者
GREENBERG, GR [1 ]
POKOLDANIEL, S [1 ]
FUNG, L [1 ]
机构
[1] UNIV TORONTO,DEPT PHYSIOL,TORONTO M5S 1A8,ONTARIO,CANADA
关键词
D O I
10.1210/en.131.3.1527
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin hypoglycemia is a potent mechanism for somatostatin secretion into the circulation. Whether the associated increase in gastric acid mediates the rise of one or both principle molecular forms of somatostatin, somatostatin-14 (S-14) and somatostatin-28 (S-28), was examined in four conscious dogs. Somatostatin molecular forms were separated by gel filtration chromatography after extraction of acidified plasma on octadecyl silyl cartridges and quantified by RIA. Basal plasma levels of S-14 and S-28 were 3.4 +/- 0.2 and 4.1 +/- 0.6 fmol/ml, respectively. After hypoglycemia induced by insulin, plasma S-14 increased by 29.5 +/- 3.9 fmol/ml (P < 0.001), and plasma S-28 increased by 7.2 +/- 0.9 fmol/ml (P < 0.01). Suppression of hypoglycemia-mediated gastric acid secretion after the administration of omeprazole or ranitidine inhibited elevations of 8-14 by 82 +/- 6% (P < 0.001) and 81 +/- 7% (P < 0.001), respectively, but had no effect on the rise of S-28. Atropine (50-mu-g/kg, iv), which also suppresses gastric acid secretion after insulin hypoglycemia, decreased S-14 by 59 +/- 3% (P < 0.01) without influencing S-28. Atropine given after omeprazole treatment, however, increased S-14 by 38.9 +/- 6.5 fmol/ml, a response that was greater than the S-14 levels observed after atropine (P < 0.001) or omeprazole (P < 0.001) alone and was equivalent to control levels. S-28 remained unaltered after atropine and omeprazole treatment. These results in conscious dogs indicate that after vagal stimulation induced by insulin hypoglycemia 1) both S-14 and S-28 are released into the circulation, but S-14 predominates; 2) gastric acid contributes directly to the stimulation of S-14, but not S-28, secretion; 3) muscarinic inhibitory mechanisms participate in the regulation of S-14 secretion, and this mechanism is amplified when vagally stimulated gastric acid secretion is suppressed; and 4) nonmuscarinic mechanisms mediate in part S-28 secretion. This study suggests the presence of a reciprocal functional relationship between gastric acid secretion and circulating S-14 that is mediated by vagal muscarinic mechanisms.
引用
收藏
页码:1527 / 1533
页数:7
相关论文
共 34 条
  • [1] DIFFERENTIAL NEURAL REGULATION OF CIRCULATING SOMATOSTATIN-14 AND SOMATOSTATIN-28 IN CONSCIOUS DOGS
    GREENBERG, GR
    AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05): : G902 - G909
  • [2] REGULATION OF SOMATOSTATIN-14 AND SOMATOSTATIN-28 SECRETION BY GASTRIC-ACID IN DOGS - DIFFERENTIAL ROLE OF CHOLECYSTOKININ
    GREENBERG, GR
    FUNG, L
    POKOLDANIEL, S
    GASTROENTEROLOGY, 1993, 105 (05) : 1387 - 1395
  • [3] EFFECT OF SOMATOSTATIN-14, AND NATURAL AND SYNTHETIC SOMATOSTATIN-28 ON PENTAGASTRIN-STIMULATED GASTRIC-ACID AND PANCREATIC SECRETIONS IN CONSCIOUS DOGS
    ESTEVE, JP
    SUSINI, C
    VAYSSE, N
    GINESTON, JL
    PRADAYROL, L
    WUNSCH, E
    RIBET, A
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1982, 6 (6-7): : 576 - 580
  • [4] SOMATOSTATIN-14 AND SOMATOSTATIN-28 - CLEARANCE AND POTENCY ON GASTRIC FUNCTION IN DOGS
    SEAL, A
    YAMADA, T
    DEBAS, H
    HOLLINSHEAD, J
    OSADCHEY, B
    APONTE, G
    WALSH, J
    AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 243 (02): : G97 - G102
  • [5] INFLUENCE OF INTRAPERITONEALLY (IP) ADMINISTERED SOMATOSTATIN-14 (SS-14) AND SOMATOSTATIN-28 (SS-28) ON SOMATOSTATIN-LIKE IMMUNOREACTIVITY (SLI), GASTRIN AND GASTRIC-ACID SECRETION IN THE RAT
    SEEFRIED, G
    SCHMIDTLER, J
    ACTA ENDOCRINOLOGICA, 1986, 111 : 30 - 31
  • [6] CIRCULATING SOMATOSTATIN-28 IS NOT A PHYSIOLOGICAL REGULATOR OF GASTRIC-ACID PRODUCTION IN MAN
    HILDEBRAND, P
    ENSINCK, JW
    BUETTIKER, J
    DREWE, J
    BURCKHARDT, B
    GYR, K
    BEGLINGER, C
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (01) : 50 - 56
  • [7] GLUCOSE-INDUCED CHANGES IN SOMATOSTATIN-14 AND SOMATOSTATIN-28 RELEASED FROM RAT HYPOTHALAMIC FRAGMENTS INVITRO
    LENGYEL, AMJ
    KRUSEMAN, ACN
    GROSSMAN, A
    REES, LH
    BESSER, GM
    LIFE SCIENCES, 1984, 35 (07) : 713 - 719
  • [8] SOMATOSTATIN-28 IS LESS POTENT THAN SOMATOSTATIN-14 AS AN INHIBITOR OF GASTRIC EXOCRINE SECRETIONS
    HIRST, BH
    CONLON, JM
    HOLLAND, J
    SHAW, B
    COY, DH
    SCHALLY, AV
    GUT, 1981, 22 (10) : A883 - A883
  • [9] SELECTIVE EFFECTS OF SOMATOSTATIN-14, SOMATOSTATIN-25 AND SOMATOSTATIN-28 ON INVITRO INSULIN AND GLUCAGON-SECRETION
    MANDARINO, L
    STENNER, D
    BLANCHARD, W
    NISSEN, S
    GERICH, J
    LING, N
    BRAZEAU, P
    BOHLEN, P
    ESCH, F
    GUILLEMIN, R
    NATURE, 1981, 291 (5810) : 76 - 77
  • [10] COMPARISON OF THE GASTRIC EXOCRINE INHIBITORY ACTIVITIES AND PLASMA KINETICS OF SOMATOSTATIN-28 AND SOMATOSTATIN-14 IN CATS
    HIRST, BH
    CONLON, JM
    COY, DH
    HOLLAND, J
    SHAW, B
    REGULATORY PEPTIDES, 1982, 4 (04) : 227 - 237